Lea J. Mertens

Von Esmarch Str. 52
Muenster, NW 48149, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: March 18, 2026

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Journal: Psychotherapy and psychosomatics

Published: February 02, 2026

Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.

Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.

Journal: Psychological review

Published: October 09, 2025

Compassionate use of psilocybin for treatment-resistant depression in Germany.

Compassionate use of psilocybin for treatment-resistant depression in Germany.

Journal: The lancet. Psychiatry

Published: August 13, 2025

Psychedelics: The pathway to implementation in the European healthcare systems.

Psychedelics: The pathway to implementation in the European healthcare systems.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: May 31, 2025

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Journal: Psychedelic medicine (New Rochelle, N.Y.)

Published: May 12, 2025

Can antidepressants negatively alter the long-term course of depressive disorders?

Can antidepressants negatively alter the long-term course of depressive disorders?

Journal: Der Nervenarzt

Published: January 10, 2025

Psychedelics in psychiatry: an open debate

Psychedelics in psychiatry: an open debate

Journal: Fortschritte der Neurologie-Psychiatrie

Published: December 12, 2024

Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment

Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment

Journal: Der Nervenarzt

Published: November 20, 2024

Effects of an intervention targeting social media app use on well-being outcomes: A randomized controlled trial.

Effects of an intervention targeting social media app use on well-being outcomes: A randomized controlled trial.

Journal: Applied psychology. Health and well-being

Published: June 04, 2024

Psilocybin as a Disease-Modifying Drug—A Salutogenic Approach in Psychiatry.

Psilocybin as a Disease-Modifying Drug—A Salutogenic Approach in Psychiatry.

Journal: Deutsches Arzteblatt international

Published: May 19, 2024

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).

Journal: Journal of psychopharmacology (Oxford, England)

Published: May 14, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026